Moderna’s two-dose vaccine has been approved for emergency use in children aged six months to five years, and Pfizer’s three-dose vaccine has been approved for children aged six months to four years. This is the last age group that has not received protection in the United States so far, as in many other countries.
The FDA has also approved the use of the Moderna vaccine to vaccinate people aged 6 to 17 years. The Pfizer vaccine has previously been approved for people over the age of five.
Many parents, nurses and clinicians have been waiting for the youngest children to be vaccinated, and the current decision allows us to protect them from the age of six months.
Wrote Robert Califf, head of the FDA. “As we have seen in the older age group, these vaccines for the youngest children provide protection against the most severe forms of Covid-19 disease, such as hospitalization and death,” he added.
The Centers for Disease Control and Prevention (CDC) should also recommend these vaccinations so that they can be started. Final approval is expected after an expert meeting of an advisory committee to be held on Friday and Saturday.
The U.S. government has announced that as soon as the FDA decides, about ten million doses of the vaccine could be launched in advance in all parts of the country, with millions more to be delivered in the coming weeks. Equipment for vaccinations, including injection needles, was also provided, the MTI reported.